Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1980 Apr 1;187(1):173–180. doi: 10.1042/bj1870173

Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors.

M Sandbjerg Hansen, I Clemmensen
PMCID: PMC1162505  PMID: 6447502

Abstract

An inhibitor of the plasma proteinase plasmin (EC 3.4.21.7) was partially purified from washed and lysed human blood platelets by (NH4)2SO4 fractionation and affinity chromatrography on Sepharose-linked purified plasminogen. The material contained none of the known plasma proteinase inhibitors when studied by crossed-immunoelectrophoresis and electroimmunoassay, but inhibited a clot-lysis-time assay and an esterolytic assay that used the synthetic substrate S-2251 (D-Val-Leu-Lys-p-nitroanilide). The inhibitory activity had the same mobility as the alpha 2-plasma proteins on preparative agarose-gel electrophoresis. Titration of the inhibitor preparation by active-site-titrated plasmin demonstrated a dissociation constant of approx. 0.1 nM. The inhibition was complete within 1 min. The inhibitor increased the mobility in agarose-gel electrophoresis of purified activator-free plasmin or 125I-labelled plasmin, as demonstrated by crossed-immunoelectrophoresis against specific immunoglobulins against plasminogen or by radioautography. The results strongly suggest the presence in platelets of a plasmin inhibitor different from the known plasma proteinase inhibitors.

Full text

PDF
173

Images in this article

178Fig. 5.
on p.178
178Fig. 6.
on p.178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Astrup T. Tissue activators of plasminogen. Fed Proc. 1966 Jan-Feb;25(1):42–51. [PubMed] [Google Scholar]
  3. Axén R., Porath J., Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature. 1967 Jun 24;214(5095):1302–1304. doi: 10.1038/2141302a0. [DOI] [PubMed] [Google Scholar]
  4. Bagdasarian A., Colman R. W. Subcellular localization and purification of platelet alpha1-antitrypsin. Blood. 1978 Jan;51(1):139–156. [PubMed] [Google Scholar]
  5. Chase T., Jr, Shaw E. Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes. Biochemistry. 1969 May;8(5):2212–2224. doi: 10.1021/bi00833a063. [DOI] [PubMed] [Google Scholar]
  6. Christensen U., Clemmensen I. Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma. Biochem J. 1978 Nov 1;175(2):635–641. doi: 10.1042/bj1750635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Christensen U., Sottrup-Jensen L., Magnusson S., Petersen T. E., Clemmensen I. Enzymic properties of the neo-plasmin-Val-422 (miniplasmin). Biochim Biophys Acta. 1979 Apr 12;567(2):472–481. doi: 10.1016/0005-2744(79)90133-5. [DOI] [PubMed] [Google Scholar]
  8. Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem. 1976 Oct 1;69(1):209–216. doi: 10.1111/j.1432-1033.1976.tb10875.x. [DOI] [PubMed] [Google Scholar]
  9. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  10. GREEN N. M., WORK E. Pancreatic trypsin inhibitor. II. Reaction with trypsin. Biochem J. 1953 May;54(2):347–352. doi: 10.1042/bj0540347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ganguly P. A low molecular weight antiplasmin of human blood platelets. Clin Chim Acta. 1972 Jul;39(2):466–468. doi: 10.1016/0009-8981(72)90068-x. [DOI] [PubMed] [Google Scholar]
  12. Ganrot P. O. Crossed immunoelectrophoresis. Scand J Clin Lab Invest Suppl. 1972;124:39–47. doi: 10.3109/00365517209102749. [DOI] [PubMed] [Google Scholar]
  13. Gilbert L. R., Wachsman J. T. Optimal conditions for the iodination of fibrinogen using immobilized lactoperoxidase. Anal Biochem. 1976 May 7;72:480–484. doi: 10.1016/0003-2697(76)90557-1. [DOI] [PubMed] [Google Scholar]
  14. Harker L. A., Slichter S. J. Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thromb Diath Haemorrh. 1974 May 15;31(2):188–203. [PubMed] [Google Scholar]
  15. Harpel P. C., Cooper N. R. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J Clin Invest. 1975 Mar;55(3):593–604. doi: 10.1172/JCI107967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hercz A. The inhibition of proteinases by human alpha1-antitrypsin. Eur J Biochem. 1974 Nov 1;49(1):287–292. doi: 10.1111/j.1432-1033.1974.tb03833.x. [DOI] [PubMed] [Google Scholar]
  17. Highsmith R. F., Rosenberg R. D. The inhibition of human plasmin by human antithrombin-heparin cofactor. J Biol Chem. 1974 Jul 25;249(14):4335–4338. [PubMed] [Google Scholar]
  18. Holmberg L., Lecander I., Persson B., Astedt B. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta. 1978 Nov 15;544(1):128–137. doi: 10.1016/0304-4165(78)90216-7. [DOI] [PubMed] [Google Scholar]
  19. Joist J. H., Niewiarowski S., Nath N., Mustard J. F. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets. J Lab Clin Med. 1976 Apr;87(4):659–669. [PubMed] [Google Scholar]
  20. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  21. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  22. Mattler L. E., Bang N. U. Serine protease specificity for peptide chromogenic substrates. Thromb Haemost. 1977 Dec 15;38(4):776–792. [PubMed] [Google Scholar]
  23. McDonagh J., Kiesselbach T. H., Wagner R. H. Factor 13 and antiplasmin activity in human platelets. Am J Physiol. 1969 Mar;216(3):508–513. doi: 10.1152/ajplegacy.1969.216.3.508. [DOI] [PubMed] [Google Scholar]
  24. Miletich J. P., Jackson C. M., Majerus P. W. Interaction of coagulation factor Xa with human platelets. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4033–4036. doi: 10.1073/pnas.74.9.4033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Moore S., Pepper D. S., Cash J. D. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Biochim Biophys Acta. 1975 Feb 27;379(2):360–369. doi: 10.1016/0005-2795(75)90143-9. [DOI] [PubMed] [Google Scholar]
  26. Moroi M., Aoki N. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem. 1976 Oct 10;251(19):5956–5965. [PubMed] [Google Scholar]
  27. Mui P. T., James H. L., Ganguly P. Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum. Br J Haematol. 1975 Apr;29(4):627–637. doi: 10.1111/j.1365-2141.1975.tb02749.x. [DOI] [PubMed] [Google Scholar]
  28. Murray J., Crawford G. P., Ogston D., Douglas A. S. Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol. 1974 Apr;26(4):661–668. doi: 10.1111/j.1365-2141.1974.tb00509.x. [DOI] [PubMed] [Google Scholar]
  29. Müllertz S., Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem J. 1976 Dec 1;159(3):545–553. doi: 10.1042/bj1590545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Müllertz S. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochem J. 1974 Nov;143(2):273–283. doi: 10.1042/bj1430273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nachman R. L., Harpel P. C. Platelet alpha2-macroglobulin and alpha1-antitrypsin. J Biol Chem. 1976 Aug 10;251(15):4512–4521. [PubMed] [Google Scholar]
  32. OUCHTERLONY O. Antigen-antibody reactions in gels. IV. Types of reactions in coordinated systems of diffusion. Acta Pathol Microbiol Scand. 1953;32(2):230–240. [PubMed] [Google Scholar]
  33. Olson P. S., Ljungqvist U., Bergentz S. E. Analysis of platelet, red cell and fibrin content in experimental arterial and venous thrombi. Thromb Res. 1974 Jul;5(1):1–19. doi: 10.1016/0049-3848(74)90106-6. [DOI] [PubMed] [Google Scholar]
  34. Osterud B., Rapaport S. I., Lavine K. K. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood. 1977 May;49(5):819–834. [PubMed] [Google Scholar]
  35. Thorell J. I., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta. 1971 Dec 28;251(3):363–369. doi: 10.1016/0005-2795(71)90123-1. [DOI] [PubMed] [Google Scholar]
  36. Thorsen S. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects. Scand J Clin Lab Invest. 1973 Jan;31(1):51–59. doi: 10.3109/00365517309082418. [DOI] [PubMed] [Google Scholar]
  37. Wakabayashi K., Fujikawa K., Abe T. Some properties of an antiplasmin substance from rabbit platelets. Thromb Diath Haemorrh. 1970 Oct 31;24(1):76–84. [PubMed] [Google Scholar]
  38. Walsh P. N. Platelet coagulant activities and hemostasis: a hypothesis. Blood. 1974 Apr;43(4):597–605. [PubMed] [Google Scholar]
  39. Wiman B., Wallén P. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound. Eur J Biochem. 1973 Jul 2;36(1):25–31. doi: 10.1111/j.1432-1033.1973.tb02880.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES